NEOGENIX ONCOLOGY INC — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2b192c35-eaac-4c22-9f2d-95635c3689c9/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2011 | $-115.5M | 2004-01-01 – 2011-12-31 | evidence 0001144204-12-039179 |
| FY 2010 | $-19.1M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-039179 |
| FY 2009 | $-35.6M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-039179 |
| FY 2008 | $-25.8M | 2008-01-01 – 2008-12-31 | evidence 0001144204-12-039179 |
| FY 2007 | $-8.4M | 2007-01-01 – 2007-12-31 | evidence 0001144204-12-039179 |
| FY 2006 | $-4.2M | 2006-01-01 – 2006-12-31 | evidence 0001144204-12-039179 |
| FY 2005 | $-2.8M | 2005-01-01 – 2005-12-31 | evidence 0001144204-12-039179 |
| FY 2004 | $-673.8k | 2004-01-01 – 2004-12-31 | evidence 0001144204-12-039179 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).